middle.news

Richter’s A$6.40 Mayne Pharma offer puts US franchises in the spotlight

9:13am on Tuesday 17th of November, 2026 AEDT • Pharmaceuticals
Read Story

Richter’s A$6.40 Mayne Pharma offer puts US franchises in the spotlight

9:13am on Tuesday 17th of November, 2026 AEDT
Key Points
  • A$6.40 cash offer values equity at approximately A$604 million
  • 99.4% premium to Mayne Pharma’s 16 November closing price
  • Board recommendation backed by shareholders representing 22.14% of shares
  • Scheme targeted for implementation in mid to late March 2027
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Mayne Pharma (ASX:MYX)
OPEN ARTICLE